Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects

A. A. Mitchell, L. Rosenberg, S. Shapiro and D. Slone

The risk of birth defects previously associated with Bendectin use in early pregnancy were evaluated in a case-control study of malformed infants whose mothers were interviewed in three regional centers; 98 infants with isolated cleft palate (CP), 221 with cleft lip with or without cleft palate (CL +/- CP), and 122 with selected heart defects (HD) were compared with 970 other malformed infants who served as controls. Relative risk estimates (with their 95% confidence limits) for first-trimester exposure to Bendectin were as follows: CP, 0.9 (0.5 to 1.5); CL +/- CP, 0.6 (0.4 to 0.8); and HD, 1.0 (0.6 to 1.6). Allowance for a large number of potentially confounding factors did not materially influence the risk estimates. These findings suggest that early in utero exposure to Bendectin does not appreciably increase the risk of oral clefts or selected cardiac defects.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factors for Persistent Pulmonary Hypertension of the Newborn
Hernandez-Diaz et al.
Pediatrics 2007;120:e272-e282.
ABSTRACT | FULL TEXT  

First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik et al.
NEJM 2007;356:2675-2683.
ABSTRACT | FULL TEXT  

Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics
Jenkins et al.
Circulation 2007;115:2995-3014.
ABSTRACT | FULL TEXT  

Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers et al.
NEJM 2006;354:579-587.
ABSTRACT | FULL TEXT  

Systematic Identification of Drugs That Cause Birth Defects -- A New Opportunity
Mitchell
NEJM 2003;349:2556-2559.
FULL TEXT  

Case-Crossover and Case-Time-Control Designs in Birth Defects Epidemiology
Hernandez-Diaz et al.
Am J Epidemiol 2003;158:385-391.
ABSTRACT | FULL TEXT  

Genetic Epidemiology and Congenital Malformations: From the Chromosome to the Crib
Hobbs et al.
Arch Pediatr Adolesc Med 2002;156:315-320.
FULL TEXT  

Neural Tube Defects in Relation to Use of Folic Acid Antagonists during Pregnancy
Hernandez-Diaz et al.
Am J Epidemiol 2001;153:961-968.
ABSTRACT | FULL TEXT  

Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects
Hernandez-Diaz et al.
NEJM 2000;343:1608-1614.
ABSTRACT | FULL TEXT